Solventum SOLV
NYSE SOLV
$89.11 -1.22 (-1.35%)
As of: Nov 9, 2026 · 9:59 AM EST

Solventum (SOLV) Gains (Losses) on Sale of Assets & Investments (2025)

Updated

Solventum (SOLV) posted Non Operating Investment Income of $31 million for Q4 2025, down 98.0% from the prior quarter.

Analysis

Solventum (SOLV) Gains (Losses) on Sale of Assets & Investments (2025) Analysis & Trends

For FY2025, Solventum's Non Operating Investment Income came in at $1.55 billion.

  • In prior years, Solventum's Non Operating Investment Income was $56 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Thermo Fisher Scientific 258.81 Bn 235.32 Bn 5.13 Bn -
2 Abbott Laboratories 189.40 Bn 163.27 Bn 7.39 Bn -
3 Danaher 162.08 Bn 141.74 Bn 3.84 Bn -
4 Intuitive Surgical 158.99 Bn 139.28 Bn 2.08 Bn -
5 Medtronic 130.53 Bn 95.78 Bn 6.34 Bn -
6 Stryker 124.82 Bn 111.01 Bn 4.25 Bn -
7 Boston Scientific 62.97 Bn 58.41 Bn 3.43 Bn -
8 Edwards Lifesciences 59.51 Bn 42.71 Bn 1.35 Bn -
9 Becton Dickinson 58.44 Bn 55.59 Bn 2.32 Bn -
10 Solventum 15.22 Bn 12.92 Bn 1.06 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 31.00 Mn
Sep 30, 2025 1.52 Bn
API Access

Solventum Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=SOLV&period=max&api_key=YOUR_API_KEY